TCRX
TScan Therapeutics, Inc.
$1.07
+0.02 (+1.90%)
At close · Jul 7
Market Cap
$70.25M
Shares
65,350,817
Earnings calls and other investor events (conferences, investor days) grouped as single events — the transcript and audio, plus, for earnings calls, the 8-K earnings release and the quarter's 10-Q or 10-K, with the reported result and management tone at a glance.
Revenue & result across quarters
Revenue ($B) YoY up YoY down artefacts
LATEST
▼54.8%
'26 Q1
26-05-06
▲286%
'25 Q4
26-03-04
▲139.4%
'25 Q3
25-11-12
▲473.9%
'25 Q2
25-08-12
▲283.6%
'25 Q1
25-05-06
▼90.8%
'24 Q4
25-03-05
▼73%
'24 Q3
24-11-12
▼83%
'24 Q2
24-08-12
▼91.7%
'24 Q1
24-04-17
▲133%
'23 Q4
24-03-06
▲15.6%
'23 Q3
23-11-09
▼22.4%
'23 Q2
23-08-10
▲125.2%
'23 Q1
23-05-10
·
'22 Q4
23-03-08
▲39.4%
'22 Q3
22-11-09
▲42.4%
'22 Q2
22-08-10
Earnings call
FY26 · Q1
2026-05-06
TScan Therapeutics, Inc. Q1 FY2026 Earnings Call
Revenue
$982,000
▼ 54.8% YoY Diluted EPS
$-0.22
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-04
TScan Therapeutics, Inc. Q4 FY2025 Earnings Call
Revenue
$2.57M*
▲ 286% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-12
TScan Therapeutics, Inc. Q3 FY2025 Earnings Call
Revenue
$2.51M
▲ 139.4% YoY Diluted EPS
$-0.28
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
TScan Therapeutics, Inc. Q2 FY2025 Earnings Call
Revenue
$3.08M
▲ 473.9% YoY Diluted EPS
$-0.28
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
TScan Therapeutics, Inc. Q1 FY2025 Earnings Call
Revenue
$2.17M
▲ 283.6% YoY Diluted EPS
$-0.26
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-05
TScan Therapeutics, Inc. Q4 FY2024 Earnings Call
Revenue
$665,000*
▼ 90.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
TScan Therapeutics, Inc. Q3 FY2024 Earnings Call
Revenue
$1.05M
▼ 73% YoY Diluted EPS
$-0.25
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-12
TScan Therapeutics, Inc. Q2 FY2024 Earnings Call
Revenue
$536,000
▼ 83% YoY Diluted EPS
$-0.28
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-17
TScan Therapeutics, Inc. Q1 FY2024 Earnings Call
Revenue
$566,000
▼ 91.7% YoY Diluted EPS
$-0.32
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-06
TScan Therapeutics, Inc. Q4 FY2023 Earnings Call
Revenue
$7.21M*
▲ 133% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-09
TScan Therapeutics, Inc. Q3 FY2023 Earnings Call
Revenue
$3.89M
▲ 15.6% YoY Diluted EPS
$-0.24
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
TScan Therapeutics, Inc. Q2 FY2023 Earnings Call
Revenue
$3.15M
▼ 22.4% YoY Diluted EPS
$-0.51
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
TScan Therapeutics, Inc. Q1 FY2023 Earnings Call
Revenue
$6.80M
▲ 125.2% YoY Diluted EPS
$-0.93
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-08
TScan Therapeutics, Inc. Q4 FY2022 Earnings Call
Revenue
$3.10M*
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-09
TScan Therapeutics, Inc. Q3 FY2022 Earnings Call
Revenue
$3.36M
▲ 39.4% YoY Diluted EPS
$-0.67
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-10
TScan Therapeutics, Inc. Q2 FY2022 Earnings Call
Revenue
$4.06M
▲ 42.4% YoY Diluted EPS
$-0.63
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
TScan Therapeutics, Inc. Q1 FY2022 Earnings Call
Revenue
$3.02M
Rev · 3q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-09
TScan Therapeutics, Inc. Q4 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-10
TScan Therapeutics, Inc. Q3 FY2021 Earnings Call
Revenue
$2.41M
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-19
TScan Therapeutics, Inc. Q2 FY2021 Earnings Call
Revenue
$2.85M
Audio
Transcript
Slides
8-K10-Q
Showing 1–20 of 20 earnings calls